The 5 analysts offering 12-month price forecasts for Idera Pharmaceuticals Inc have a median target of 7.00, with a high estimate of 10.00 and a low estimate of 5.00. The median estimate represents a +227.10% increase from the last price of 2.14.
The current consensus among 6 polled investment analysts is to Buy stock in Idera Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.24
Reporting Date Nov 04
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.